» Articles » PMID: 9302893

The Crippling Consequences of Fractures and Their Impact on Quality of Life

Overview
Journal Am J Med
Specialty General Medicine
Date 1997 Aug 18
PMID 9302893
Citations 196
Authors
Affiliations
Soon will be listed here.
Abstract

Around 40% of white women and 13% of white men in the United States have at least one fragility fracture after the age of 50 years. The risk of fracture increases with advancing age and progressive loss of bone mass, and varies with the population being considered. The age-adjusted incidence of fragility fractures in both sexes is 25% lower in Britain and many areas of Europe than in the United States. Mortality 5 years after hip or vertebral fracture is about 20% in excess of that expected; mortality rate is highest in men > 75 years suffering from a variety of chronic diseases. Most excess deaths occur in the first 6 months after hip fracture. One year after hip fracture, 40% of patients are still unable to walk independently, 60% have difficulty with at least one essential activity of daily living, and 80% are restricted in other activities, such as driving and grocery shopping. Moreover, 27% of these patients enter a nursing home for the first time. Less is known of the epidemiology of vertebral fractures and of the associated mortality and morbidity. Although an estimated 30% of postmenopausal U.S. white women have osteoporosis, and 1 in 4 has at least one vertebral deformity, two thirds of vertebral fractures remain undiagnosed. After a clinically diagnosed vertebral fracture, survival rate decreases gradually from that expected without fracture. Women with severe vertebral deformities have a consistently higher risk of back pain and height loss. An accurate assessment of the risk of fractures associated with osteoporosis and of their impact on quality of life is essential if appropriate and cost-effective interventions are to be designed for different populations.

Citing Articles

Impact of Treatment Modalities and Fracture Stability on Survival in Thoracolumbar Fractures: A 5-Year Observational Study.

Viola R, Juhasz A, Suvegh D, Veres D, Gati A, Viola A J Clin Med. 2025; 14(3).

PMID: 39941604 PMC: 11818757. DOI: 10.3390/jcm14030933.


Cost-effectiveness analysis of romosozumab for severe postmenopausal osteoporosis at very high risk of fracture in Mexico.

Diaz Martinez J, Aubry de Maraumont T, Natty Sanchez E, Camacho Cordero L, Yeh E PLoS One. 2025; 20(2):e0299673.

PMID: 39919094 PMC: 11805434. DOI: 10.1371/journal.pone.0299673.


Effect of oral trehalose supplementation on inflammation and wound healing in patients with peri-trochanteric fractures: study protocol for a randomised clinical trial.

Zandi R, Tavallaei Zavareh A, Mehrvar A, Jowshan M, Sahebkar A, Nikooyeh B BMJ Open. 2024; 14(12):e092092.

PMID: 39627130 PMC: 11624808. DOI: 10.1136/bmjopen-2024-092092.


Perceived Health Status Predicts Resilience after Hip Fracture in Older People.

Lelli D, Iuorio M, Antonelli Incalzi R, Pedone C Medicina (Kaunas). 2024; 60(10).

PMID: 39459408 PMC: 11509480. DOI: 10.3390/medicina60101621.


Osteoporosis and obesity in the South East of Caspian Seashore and its relationship to osteoporosis prevalence in Iran.

Shafaroudi M, Rezaei N, Mohammadnejiad B, Usefi G, Malekzadeh Shafaroudi A Caspian J Intern Med. 2024; 15(4):629-635.

PMID: 39359434 PMC: 11444095. DOI: 10.22088/cjim.15.4.629.